dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs28371706
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr22:42129770 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- G>A / G>C / G>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
A=0.058268 (15423/264690, TOPMED)A=0.01306 (636/48696, ALFA)A=0.05849 (756/12926, GO-ESP) (+ 6 more)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
-
CYP2D6 : Missense VariantLOC102723722 : 2KB Upstream Variant
- Publications
- 29 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
| Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
|---|---|---|---|---|---|---|---|---|
| Total | Global | 48790 | G=0.98692 | A=0.01308, T=0.00000 | 0.975774 | 0.001927 | 0.0223 | 32 |
| European | Sub | 35378 | G=0.99774 | A=0.00226, T=0.00000 | 0.995534 | 0.000057 | 0.00441 | 6 |
| African | Sub | 5142 | G=0.9107 | A=0.0893, T=0.0000 | 0.835084 | 0.013613 | 0.151303 | 7 |
| African Others | Sub | 148 | G=0.851 | A=0.149, T=0.000 | 0.756757 | 0.054054 | 0.189189 | 3 |
| African American | Sub | 4994 | G=0.9125 | A=0.0875, T=0.0000 | 0.837405 | 0.012415 | 0.15018 | 5 |
| Asian | Sub | 164 | G=1.000 | A=0.000, T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| East Asian | Sub | 110 | G=1.000 | A=0.000, T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| Other Asian | Sub | 54 | G=1.00 | A=0.00, T=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Latin American 1 | Sub | 484 | G=0.969 | A=0.031, T=0.000 | 0.946281 | 0.008264 | 0.045455 | 8 |
| Latin American 2 | Sub | 612 | G=1.000 | A=0.000, T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| South Asian | Sub | 94 | G=1.00 | A=0.00, T=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Other | Sub | 6916 | G=0.9879 | A=0.0121, T=0.0000 | 0.978311 | 0.002603 | 0.019086 | 32 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| TopMed | Global | Study-wide | 264690 | G=0.941732 | A=0.058268 |
| Allele Frequency Aggregator | Total | Global | 48696 | G=0.98694 | A=0.01306, T=0.00000 |
| Allele Frequency Aggregator | European | Sub | 35302 | G=0.99779 | A=0.00221, T=0.00000 |
| Allele Frequency Aggregator | Other | Sub | 6898 | G=0.9878 | A=0.0122, T=0.0000 |
| Allele Frequency Aggregator | African | Sub | 5142 | G=0.9107 | A=0.0893, T=0.0000 |
| Allele Frequency Aggregator | Latin American 2 | Sub | 612 | G=1.000 | A=0.000, T=0.000 |
| Allele Frequency Aggregator | Latin American 1 | Sub | 484 | G=0.969 | A=0.031, T=0.000 |
| Allele Frequency Aggregator | Asian | Sub | 164 | G=1.000 | A=0.000, T=0.000 |
| Allele Frequency Aggregator | South Asian | Sub | 94 | G=1.00 | A=0.00, T=0.00 |
| GO Exome Sequencing Project | Global | Study-wide | 12926 | G=0.94151 | A=0.05849 |
| GO Exome Sequencing Project | European American | Sub | 8554 | G=0.9982 | A=0.0018 |
| GO Exome Sequencing Project | African American | Sub | 4372 | G=0.8305 | A=0.1695 |
| 1000Genomes_30x | Global | Study-wide | 6404 | G=0.9363 | A=0.0629, T=0.0008 |
| 1000Genomes_30x | African | Sub | 1786 | G=0.7800 | A=0.2200, T=0.0000 |
| 1000Genomes_30x | Europe | Sub | 1266 | G=0.9976 | A=0.0024, T=0.0000 |
| 1000Genomes_30x | South Asian | Sub | 1202 | G=1.0000 | A=0.0000, T=0.0000 |
| 1000Genomes_30x | East Asian | Sub | 1170 | G=1.0000 | A=0.0000, T=0.0000 |
| 1000Genomes_30x | American | Sub | 980 | G=0.988 | A=0.007, T=0.005 |
| 1000Genomes | Global | Study-wide | 5008 | G=0.9409 | A=0.0591 |
| 1000Genomes | African | Sub | 1322 | G=0.7821 | A=0.2179 |
| 1000Genomes | East Asian | Sub | 1008 | G=1.0000 | A=0.0000 |
| 1000Genomes | Europe | Sub | 1006 | G=0.9980 | A=0.0020 |
| 1000Genomes | South Asian | Sub | 978 | G=1.000 | A=0.000 |
| 1000Genomes | American | Sub | 694 | G=0.991 | A=0.009 |
| Genome-wide autozygosity in Daghestan | Global | Study-wide | 1128 | G=0.9973 | A=0.0027 |
| Genome-wide autozygosity in Daghestan | Daghestan | Sub | 624 | G=1.000 | A=0.000 |
| Genome-wide autozygosity in Daghestan | Near_East | Sub | 140 | G=0.979 | A=0.021 |
| Genome-wide autozygosity in Daghestan | Central Asia | Sub | 122 | G=1.000 | A=0.000 |
| Genome-wide autozygosity in Daghestan | Europe | Sub | 108 | G=1.000 | A=0.000 |
| Genome-wide autozygosity in Daghestan | South Asian | Sub | 98 | G=1.00 | A=0.00 |
| Genome-wide autozygosity in Daghestan | Caucasus | Sub | 36 | G=1.00 | A=0.00 |
| PharmGKB Aggregated | Global | Study-wide | 356 | G=0.952 | A=0.048 |
| PharmGKB Aggregated | PA149584071 | Sub | 356 | G=0.952 | A=0.048 |
| Qatari | Global | Study-wide | 214 | G=0.944 | A=0.056 |
| SGDP_PRJ | Global | Study-wide | 30 | G=0.40 | A=0.57, T=0.03 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 22 | NC_000022.11:g.42129770G>A |
| GRCh38.p14 chr 22 | NC_000022.11:g.42129770G>C |
| GRCh38.p14 chr 22 | NC_000022.11:g.42129770G>T |
| gene/pseudogene RefSeqGene (LRG_303) | NG_008376.4:g.6041C>T |
| gene/pseudogene RefSeqGene (LRG_303) | NG_008376.4:g.6041C>G |
| gene/pseudogene RefSeqGene (LRG_303) | NG_008376.4:g.6041C>A |
| GRCh38.p14 chr 22 novel patch HSCHR22_8_CTG1 | NW_015148968.1:g.7511G>A |
| GRCh38.p14 chr 22 novel patch HSCHR22_8_CTG1 | NW_015148968.1:g.7511G>C |
| GRCh38.p14 chr 22 novel patch HSCHR22_8_CTG1 | NW_015148968.1:g.7511G>T |
| GRCh38.p14 chr 22 novel patch HSCHR22_7_CTG1 | NW_014040931.1:g.23359G>A |
| GRCh38.p14 chr 22 novel patch HSCHR22_7_CTG1 | NW_014040931.1:g.23359G>C |
| GRCh38.p14 chr 22 novel patch HSCHR22_7_CTG1 | NW_014040931.1:g.23359G>T |
| GRCh38.p14 chr 22 novel patch HSCHR22_5_CTG1 | NW_009646208.1:g.15336G>A |
| GRCh38.p14 chr 22 novel patch HSCHR22_5_CTG1 | NW_009646208.1:g.15336G>C |
| GRCh38.p14 chr 22 novel patch HSCHR22_5_CTG1 | NW_009646208.1:g.15336G>T |
| GRCh38.p14 chr 22 alt locus HSCHR22_2_CTG1 | NW_004504305.1:g.52097G>A |
| GRCh38.p14 chr 22 alt locus HSCHR22_2_CTG1 | NW_004504305.1:g.52097G>C |
| GRCh38.p14 chr 22 alt locus HSCHR22_2_CTG1 | NW_004504305.1:g.52097G>T |
| GRCh38.p14 chr 22 alt locus HSCHR22_3_CTG1 | NT_187682.1:g.52111G>A |
| GRCh38.p14 chr 22 alt locus HSCHR22_3_CTG1 | NT_187682.1:g.52111G>C |
| GRCh38.p14 chr 22 alt locus HSCHR22_3_CTG1 | NT_187682.1:g.52111G>T |
| GRCh37.p13 chr 22 | NC_000022.10:g.42525772G>A |
| GRCh37.p13 chr 22 | NC_000022.10:g.42525772G>C |
| GRCh37.p13 chr 22 | NC_000022.10:g.42525772G>T |
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| CYP2D6 transcript variant 1 | NM_000106.6:c.320C>T | T [ACC] > I [ATC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 1 | NP_000097.3:p.Thr107Ile | T (Thr) > I (Ile) | Missense Variant |
| CYP2D6 transcript variant 1 | NM_000106.6:c.320C>G | T [ACC] > S [AGC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 1 | NP_000097.3:p.Thr107Ser | T (Thr) > S (Ser) | Missense Variant |
| CYP2D6 transcript variant 1 | NM_000106.6:c.320C>A | T [ACC] > N [AAC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 1 | NP_000097.3:p.Thr107Asn | T (Thr) > N (Asn) | Missense Variant |
| CYP2D6 transcript variant 2 | NM_001025161.3:c.320C>T | T [ACC] > I [ATC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 2 | NP_001020332.2:p.Thr107Ile | T (Thr) > I (Ile) | Missense Variant |
| CYP2D6 transcript variant 2 | NM_001025161.3:c.320C>G | T [ACC] > S [AGC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 2 | NP_001020332.2:p.Thr107Ser | T (Thr) > S (Ser) | Missense Variant |
| CYP2D6 transcript variant 2 | NM_001025161.3:c.320C>A | T [ACC] > N [AAC] | Coding Sequence Variant |
| cytochrome P450 2D6 isoform 2 | NP_001020332.2:p.Thr107Asn | T (Thr) > N (Asn) | Missense Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
| ClinVar Accession | Disease Names | Clinical Significance |
|---|---|---|
| RCV000734612.6 | not provided | Likely-Benign,Other |
| RCV001030445.2 | Deutetrabenazine response | Drug-Response |
| RCV001093718.2 | Tamoxifen response | Drug-Response |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | G= | A | C | T |
|---|---|---|---|---|
| GRCh38.p14 chr 22 | NC_000022.11:g.42129770= | NC_000022.11:g.42129770G>A | NC_000022.11:g.42129770G>C | NC_000022.11:g.42129770G>T |
| gene/pseudogene RefSeqGene (LRG_303) | NG_008376.4:g.6041= | NG_008376.4:g.6041C>T | NG_008376.4:g.6041C>G | NG_008376.4:g.6041C>A |
| CYP2D6 transcript variant 1 | NM_000106.6:c.320= | NM_000106.6:c.320C>T | NM_000106.6:c.320C>G | NM_000106.6:c.320C>A |
| CYP2D6 transcript variant 1 | NM_000106.5:c.320= | NM_000106.5:c.320C>T | NM_000106.5:c.320C>G | NM_000106.5:c.320C>A |
| CYP2D6 transcript variant 2 | NM_001025161.3:c.320= | NM_001025161.3:c.320C>T | NM_001025161.3:c.320C>G | NM_001025161.3:c.320C>A |
| CYP2D6 transcript variant 2 | NM_001025161.2:c.320= | NM_001025161.2:c.320C>T | NM_001025161.2:c.320C>G | NM_001025161.2:c.320C>A |
| GRCh38.p14 chr 22 novel patch HSCHR22_8_CTG1 | NW_015148968.1:g.7511= | NW_015148968.1:g.7511G>A | NW_015148968.1:g.7511G>C | NW_015148968.1:g.7511G>T |
| GRCh38.p14 chr 22 novel patch HSCHR22_7_CTG1 | NW_014040931.1:g.23359= | NW_014040931.1:g.23359G>A | NW_014040931.1:g.23359G>C | NW_014040931.1:g.23359G>T |
| GRCh38.p14 chr 22 novel patch HSCHR22_5_CTG1 | NW_009646208.1:g.15336= | NW_009646208.1:g.15336G>A | NW_009646208.1:g.15336G>C | NW_009646208.1:g.15336G>T |
| GRCh38.p14 chr 22 alt locus HSCHR22_2_CTG1 | NW_004504305.1:g.52097= | NW_004504305.1:g.52097G>A | NW_004504305.1:g.52097G>C | NW_004504305.1:g.52097G>T |
| GRCh38.p14 chr 22 alt locus HSCHR22_3_CTG1 | NT_187682.1:g.52111= | NT_187682.1:g.52111G>A | NT_187682.1:g.52111G>C | NT_187682.1:g.52111G>T |
| GRCh37.p13 chr 22 | NC_000022.10:g.42525772= | NC_000022.10:g.42525772G>A | NC_000022.10:g.42525772G>C | NC_000022.10:g.42525772G>T |
| cytochrome P450 2D6 isoform 1 | NP_000097.3:p.Thr107= | NP_000097.3:p.Thr107Ile | NP_000097.3:p.Thr107Ser | NP_000097.3:p.Thr107Asn |
| cytochrome P450 2D6 isoform 2 | NP_001020332.2:p.Thr107= | NP_001020332.2:p.Thr107Ile | NP_001020332.2:p.Thr107Ser | NP_001020332.2:p.Thr107Asn |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | BIOVENTURES | ss32476039 | May 24, 2005 (125) |
| 2 | PHARMGKB_AB_DME | ss84158076 | Dec 15, 2007 (130) |
| 3 | CORNELL | ss86241437 | Mar 23, 2008 (129) |
| 4 | SNP500CANCER | ss105440153 | Feb 05, 2009 (130) |
| 5 | 1000GENOMES | ss114257423 | Jan 25, 2009 (130) |
| 6 | EGP_SNPS | ss159831286 | Dec 01, 2009 (131) |
| 7 | COMPLETE_GENOMICS | ss169359480 | Jul 04, 2010 (132) |
| 8 | BUSHMAN | ss204099761 | Jul 04, 2010 (132) |
| 9 | 1000GENOMES | ss228698362 | Jul 14, 2010 (132) |
| 10 | NHLBI-ESP | ss342544636 | May 09, 2011 (134) |
| 11 | 1000GENOMES | ss491194354 | May 04, 2012 (137) |
| 12 | EXOME_CHIP | ss491572625 | May 04, 2012 (137) |
| 13 | CLINSEQ_SNP | ss491825746 | May 04, 2012 (137) |
| 14 | TISHKOFF | ss566667084 | Apr 25, 2013 (138) |
| 15 | JMKIDD_LAB | ss1067607087 | Aug 21, 2014 (142) |
| 16 | 1000GENOMES | ss1367336211 | Aug 21, 2014 (142) |
| 17 | HAMMER_LAB | ss1397786150 | Sep 08, 2015 (146) |
| 18 | CLINVAR | ss1457608664 | Nov 23, 2014 (136) |
| 19 | EVA_EXAC | ss1694379589 | Apr 01, 2015 (144) |
| 20 | EVA_EXAC | ss1694379590 | Apr 01, 2015 (144) |
| 21 | HAMMER_LAB | ss1809806582 | Sep 08, 2015 (146) |
| 22 | WEILL_CORNELL_DGM | ss1938961307 | Feb 12, 2016 (147) |
| 23 | ILLUMINA | ss1959984049 | Feb 12, 2016 (147) |
| 24 | JJLAB | ss2030253499 | Sep 14, 2016 (149) |
| 25 | GNOMAD | ss2745192102 | Nov 08, 2017 (151) |
| 26 | GNOMAD | ss2750571830 | Nov 08, 2017 (151) |
| 27 | GNOMAD | ss2974893852 | Nov 08, 2017 (151) |
| 28 | AFFY | ss2985240512 | Nov 08, 2017 (151) |
| 29 | AFFY | ss2985857677 | Nov 08, 2017 (151) |
| 30 | ILLUMINA | ss3022190905 | Nov 08, 2017 (151) |
| 31 | CSIRBIOHTS | ss3029638778 | Nov 08, 2017 (151) |
| 32 | ILLUMINA | ss3652655257 | Oct 12, 2018 (152) |
| 33 | ILLUMINA | ss3654008766 | Oct 12, 2018 (152) |
| 34 | EVA_DECODE | ss3708287386 | Jul 13, 2019 (153) |
| 35 | KHV_HUMAN_GENOMES | ss3822593693 | Jul 13, 2019 (153) |
| 36 | EVA | ss3825454887 | Apr 27, 2020 (154) |
| 37 | SGDP_PRJ | ss3890637723 | Apr 27, 2020 (154) |
| 38 | FSA-LAB | ss3984237335 | Apr 26, 2021 (155) |
| 39 | EVA | ss3986866498 | Apr 26, 2021 (155) |
| 40 | TOPMED | ss5110781171 | Apr 26, 2021 (155) |
| 41 | TOMMO_GENOMICS | ss5232837247 | Apr 26, 2021 (155) |
| 42 | TOMMO_GENOMICS | ss5232837248 | Apr 26, 2021 (155) |
| 43 | EVA | ss5237618467 | Apr 26, 2021 (155) |
| 44 | EVA | ss5237618468 | Apr 26, 2021 (155) |
| 45 | 1000G_HIGH_COVERAGE | ss5311255713 | Oct 16, 2022 (156) |
| 46 | EVA | ss5441587728 | Oct 16, 2022 (156) |
| 47 | HUGCELL_USP | ss5503082737 | Oct 16, 2022 (156) |
| 48 | HUGCELL_USP | ss5503082738 | Oct 16, 2022 (156) |
| 49 | EVA | ss5512474031 | Oct 16, 2022 (156) |
| 50 | 1000G_HIGH_COVERAGE | ss5618884899 | Oct 16, 2022 (156) |
| 51 | SANFORD_IMAGENETICS | ss5624504246 | Oct 16, 2022 (156) |
| 52 | SANFORD_IMAGENETICS | ss5664576761 | Oct 16, 2022 (156) |
| 53 | TOMMO_GENOMICS | ss5794029239 | Oct 16, 2022 (156) |
| 54 | TOMMO_GENOMICS | ss5794029240 | Oct 16, 2022 (156) |
| 55 | EVA | ss5822131258 | Oct 16, 2022 (156) |
| 56 | EVA | ss5847519180 | Oct 16, 2022 (156) |
| 57 | EVA | ss5847946441 | Oct 16, 2022 (156) |
| 58 | EVA | ss5959434939 | Oct 16, 2022 (156) |
| 59 | 1000Genomes | NC_000022.10 - 42525772 | Oct 12, 2018 (152) |
| 60 | 1000Genomes_30x | NC_000022.11 - 42129770 | Oct 16, 2022 (156) |
| 61 | Genome-wide autozygosity in Daghestan | NC_000022.9 - 40855716 | Apr 27, 2020 (154) |
| 62 |
ExAC
Submission ignored due to conflicting rows: |
- | Oct 12, 2018 (152) |
| 63 |
ExAC
Submission ignored due to conflicting rows: |
- | Oct 12, 2018 (152) |
| 64 |
gnomAD - Genomes
Submission ignored due to conflicting rows: |
- | Apr 26, 2021 (155) |
| 65 |
gnomAD - Genomes
Submission ignored due to conflicting rows: |
- | Apr 26, 2021 (155) |
| 66 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
| 67 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
| 68 | GO Exome Sequencing Project | NC_000022.10 - 42525772 | Oct 12, 2018 (152) |
| 69 | PharmGKB Aggregated | NC_000022.11 - 42129770 | Apr 27, 2020 (154) |
| 70 | Qatari | NC_000022.10 - 42525772 | Apr 27, 2020 (154) |
| 71 | SGDP_PRJ | NC_000022.10 - 42525772 | Apr 27, 2020 (154) |
| 72 |
8.3KJPN
Submission ignored due to conflicting rows: |
- | Apr 26, 2021 (155) |
| 73 |
8.3KJPN
Submission ignored due to conflicting rows: |
- | Apr 26, 2021 (155) |
| 74 |
14KJPN
Submission ignored due to conflicting rows: |
- | Oct 16, 2022 (156) |
| 75 |
14KJPN
Submission ignored due to conflicting rows: |
- | Oct 16, 2022 (156) |
| 76 | TopMed | NC_000022.11 - 42129770 | Apr 26, 2021 (155) |
| 77 | ALFA | NC_000022.11 - 42129770 | Apr 26, 2021 (155) |
| 78 | ClinVar | RCV000734612.6 | Oct 16, 2022 (156) |
| 79 | ClinVar | RCV001030445.2 | Oct 16, 2022 (156) |
| 80 | ClinVar | RCV001093718.2 | Oct 16, 2022 (156) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
| Associated ID | History Updated (Build) |
|---|---|
| rs59604033 | May 25, 2008 (130) |
| rs587777915 | Feb 02, 2015 (136) |
| Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
|---|---|---|---|
| 300101, ss114257423, ss169359480, ss204099761, ss491825746, ss1397786150 | NC_000022.9:40855715:G:A | NC_000022.11:42129769:G:A | (self) |
| 80894631, 1911716, 21003229, 42654703, ss228698362, ss342544636, ss491194354, ss491572625, ss566667084, ss1067607087, ss1367336211, ss1694379589, ss1809806582, ss1938961307, ss1959984049, ss2030253499, ss2745192102, ss2750571830, ss2974893852, ss2985240512, ss2985857677, ss3022190905, ss3029638778, ss3652655257, ss3654008766, ss3825454887, ss3890637723, ss3984237335, ss3986866498, ss5237618467, ss5237618468, ss5441587728, ss5512474031, ss5624504246, ss5664576761, ss5822131258, ss5847519180, ss5847946441, ss5959434939 | NC_000022.10:42525771:G:A | NC_000022.11:42129769:G:A | (self) |
| RCV000734612.6, RCV001030445.2, RCV001093718.2, 106410834, 7684, 385890118, 10803165722, ss3708287386, ss3822593693, ss5110781171, ss5311255713, ss5503082737, ss5618884899 | NC_000022.11:42129769:G:A | NC_000022.11:42129769:G:A | (self) |
| ss32476039, ss84158076, ss86241437, ss105440153, ss159831286 | NT_011520.12:21916340:G:A | NC_000022.11:42129769:G:A | (self) |
| ss1457608664 | NT_011520.13:23420205:G:A | NC_000022.11:42129769:G:A | (self) |
| ss5232837247 | NC_000022.10:42525771:G:C | NC_000022.11:42129769:G:C | (self) |
| ss5794029239 | NC_000022.11:42129769:G:C | NC_000022.11:42129769:G:C | |
| 42654703, ss1694379590, ss2745192102, ss2750571830, ss2974893852, ss3890637723, ss3986866498, ss5232837248, ss5512474031 | NC_000022.10:42525771:G:T | NC_000022.11:42129769:G:T | (self) |
| 106410834, 10803165722, ss5503082738, ss5618884899, ss5794029240 | NC_000022.11:42129769:G:T | NC_000022.11:42129769:G:T | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
| PMID | Title | Author | Year | Journal |
|---|---|---|---|---|
| 18547414 | Genotyping panel for assessing response to cancer chemotherapy. | Dai Z et al. | 2008 | BMC medical genomics |
| 19164093 | Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects. | Matimba A et al. | 2009 | Human genomics |
| 21480951 | Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. | Lim JS et al. | 2011 | British journal of clinical pharmacology |
| 21790905 | CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. | Levran O et al. | 2013 | Addiction biology |
| 22111602 | Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians. | Brown KC et al. | 2012 | Pharmacogenomics |
| 22482072 | Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics. | Cacabelos R et al. | 2012 | International journal of Alzheimer's disease |
| 23133420 | Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin. | Suarez-Kurtz G et al. | 2012 | Frontiers in pharmacology |
| 25266489 | Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China. | Zhang J et al. | 2014 | BMC genetics |
| 26091847 | Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China. | Wang L et al. | 2015 | BMC genetics |
| 26369774 | Impact of New Genomic Technologies on Understanding Adverse Drug Reactions. | Maggo SD et al. | 2016 | Clinical pharmacokinetics |
| 26793106 | CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping. | Riffel AK et al. | 2015 | Frontiers in pharmacology |
| 27108086 | Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method. | Ben S et al. | 2016 | Human genomics |
| 27233804 | Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China. | Jin T et al. | 2016 | BMC genetics |
| 27467145 | Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses. | Silvino AC et al. | 2016 | PloS one |
| 27785397 | CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia. | Kuzmanovska M et al. | 2015 | Balkan journal of medical genetics |
| 28603633 | In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestane. | Peterson A et al. | 2017 | Pharmacology research & perspectives |
| 29193749 | Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years. | Borobia AM et al. | 2018 | Clinical and translational science |
| 29681089 | Genetic variation in biotransformation enzymes, air pollution exposures, and risk of spina bifida. | Padula AM et al. | 2018 | American journal of medical genetics. Part A |
| 30068618 | Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark. | Collin LJ et al. | 2018 | BMJ open |
| 30409984 | Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics. | John SE et al. | 2018 | Scientific reports |
| 31019283 | Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests. | Thauvin-Robinet C et al. | 2019 | European journal of human genetics |
| 31858263 | Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population. | Skadrić I et al. | 2020 | International journal of legal medicine |
| 32326111 | Role of Genetic Variations in the Hepatic Handling of Drugs. | Marin JJG et al. | 2020 | International journal of molecular sciences |
| 32639515 | Bayesian Pathway Analysis for Complex Interactions. | Baurley JW et al. | 2020 | American journal of epidemiology |
| 33519226 | Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. | Fernandes MR et al. | 2021 | Pharmacogenomics and personalized medicine |
| 33875422 | Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. | Pernaute-Lau L et al. | 2021 | Antimicrobial agents and chemotherapy |
| 34385834 | Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process. | Borro M et al. | 2021 | Pharmacogenomics and personalized medicine |
| 34621706 | Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. | Kim B et al. | 2021 | Translational and clinical pharmacology |
| 34958284 | Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes. | Muyambo S et al. | 2022 | Omics |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.